Evidence map›Paper›PMID 41087371›Full record

ArticleNature communications2025

A molecular circuit regulates fate plasticity in emerging and adult AT2 cells.

Amitoj S Sawhney, Brian J Deskin, Junming Cai, Daniel Gibbard, Gibran Ali, Annika Utoft, Xianmei Qi, Aaron Olson, Hannah Hausman, Liberty Sabol and 12 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Amitoj S Sawhney *Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID http://orcid.org/0009-0007-2472-079X
Brian J Deskin *Molecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7850-5146
Junming CaiDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Daniel GibbardDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Gibran AliDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-0499-9937
Annika UtoftDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Xianmei QiDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Aaron OlsonDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Hannah HausmanDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Liberty SabolDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Shannon HolmbergDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Ria ShahDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Rachel WarrenDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-9438-2975
Stijn De LangheDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-3867-4572
Zintis IndeMolecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5564-1698
Kristopher A SarosiekMolecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4618-5085
Evan LemireMolecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Adam HaberMolecular and Integrative Physiological Sciences Program, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4229-2852
Liu WangDepartment of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Scottsdale, AZ, USA.ORCID http://orcid.org/0000-0001-8252-0170
Zong WeiDepartment of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Scottsdale, AZ, USA.ORCID http://orcid.org/0000-0002-4691-0101
Rui BeneditoMolecular Genetics of Angiogenesis Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.ORCID http://orcid.org/0000-0003-2458-3055
Douglas G BrownfieldDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. brownfield.douglas@mayo.edu.ORCID http://orcid.org/0000-0003-4769-1518

Funding

Cell competition in pulmonary fibrosis and ARDSR35HL161169 · NHLBI · MAYO CLINIC ROCHESTER · PI Stijn Piet Johan De Langhe · 2022 to 2026
$4.7M
Developmental regulation of apoptosis as a modifiable driver of radiotherapy-induced neurocognitive impairment in pediatric patientsR37CA248565 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Kristopher Andrew Sarosiek · 2020 to 2026
$2.6M
Role of SIRT7 in the Pancreatic Beta CellsR01DK132651 · NIDDK · MAYO CLINIC ARIZONA · PI Zong Wei · 2022 to 2026
$2.1M
Molecular Determinants of the Alveolar Epithelial Plasticity WindowR01HL169382 · NHLBI · MAYO CLINIC ROCHESTER · PI Douglas Glenn Brownfield · 2024 to 2026
$1.9M
INTEGRATION OF MECHANICAL AND MOLECULAR CUES DURING DISTAL LUNG DEVELOPMENTR01HL171056 · NHLBI · MAYO CLINIC ROCHESTER · PI Douglas Glenn Brownfield · 2024 to 2026
$1.8M
Identifying targetable apoptotic vulnerabilities for the treatment of AL amyloidosisR01DK125263 · NIDDK · HARVARD SCHOOL OF PUBLIC HEALTH · PI SAROSIEK, KRISTOPHER ANDREW · 2020 to 2023
$1.4M
Reverse Engineering the Alveolus: From cellular to microenvironment specification during developmentR00HL127267 · NHLBI · MAYO CLINIC ROCHESTER · PI BROWNFIELD, DOUGLAS GLENN · 2019 to 2021
$747k
Reverse Engineering the Alveolus: From cellular to microenvironment specification during developmentK99HL127267 · NHLBI · STANFORD UNIVERSITY · PI BROWNFIELD, DOUGLAS GLENN · 2016 to 2017
$261k
NCI NIH HHS R37 CA248565NHLBI NIH HHS K99 HL127267NHLBI NIH HHS R00 HL127267NHLBI NIH HHS R01 HL169382NHLBI NIH HHS R01 HL171056NHLBI NIH HHS R35 HL161169NIDDK NIH HHS R01 DK125263NIDDK NIH HHS R01 DK132651U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R00HL127267U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL171056
6 · The paper itself

Abstract

Alveolar Type 1 and Type 2 cells are vital for lung gas exchange and become compromised in several diseases. While key differentiation signals are known, their emergence and fate plasticity are unclear. Here we show in the embryonic lung that single AT2s emerge at intermediate zones, extrude, and connect with nearby epithelium via interlumenal junctioning. We observe AT2s retain fate plasticity until the bZIP transcription factor C/EBPα suppresses Notch signaling at a novel Dlk1 enhancer. Both Dlk1 and Cebpa are regulated by the polycomb repressive complex (PRC2), which together form a "pulse generator" circuit that times Dlk1 expression and thus Notch activation, resulting in a "salt and pepper" pattern of AT1 and AT2 fate. In injured adult lungs, C/EBPα downregulation is required to re-access AT2 fate plasticity and is mediated by the dominant negative C/EBP family member CHOP. Finally, Cebpa loss also activates a "defender" AT2 state, distinct from its reparative state, and we propose AT2s toggle between either state following infection to protect and repair alveoli.

Indexed as

Alveolar Epithelial CellsPulmonary AlveoliAnimalsCalcium-Binding ProteinsCCAAT-Enhancer-Binding Protein-alphaCCAAT-Enhancer-Binding ProteinsCell DifferentiationCell PlasticityLungMiceMice, Inbred C57BLReceptors, NotchSignal TransductionTranscription Factor CHOPCalcium-Binding ProteinsCCAAT-Enhancer-Binding Protein-alphaCCAAT-Enhancer-Binding ProteinsCEBPA protein, mouseDlk1 protein, mouseReceptors, NotchTranscription Factor CHOP

Identifiers

PMID41087371
PMCPMC12521654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.